Acasă › Cancer pancreatic › Texas › Dallas
Studii clinice pentru Cancer pancreatic în Dallas, TX
22 studii pentru Cancer pancreatic caută participanți în și în jurul orașului Dallas (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
DESTINY-PANTUMOUR04
În curs de recrutareStudiu observațional
- Research Site, Dallas
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
În curs de recrutareFaza 2/3
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- University of Texas Southwestern Medical Center-William P. Clements Jr. University Hospital, Dallas
- University of Texas Southwestern Medical Center-Zale Lipshy University Hospital, Dallas
- și încă 1
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
În curs de recrutareFaza 3
- Texas Oncology - DFW, Dallas
- University of Texas, Southwestern Medical Center, Dallas
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
În curs de recrutareFaza 3
- Investigative Site US067, Dallas
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
În curs de recrutareFaza 3
- UT Southwestern Medical Center at Dallas, Dallas
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
În curs de recrutareFaza 1
- NEXT - Dallas, Dallas
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
În curs de recrutareStudiu observațional
- University of Texas Southwestern/Children's Medical Center, Dallas
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
În curs de recrutareStudiu observațional
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
În curs de recrutareFaza 1
- University of Texas Southwestern Medical Center, Dallas
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
În curs de recrutareFaza 1
- Ut Southwestern, Dallas
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
În curs de recrutareFaza 3
- Parkland Memorial Hospital, Dallas
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial
În curs de recrutareFaza 3
- University of Texas Southwestern Medical Center, Dallas
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
În curs de recrutareFaza 2
- Texas Oncology - DFW, Dallas
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
În curs de recrutareFaza 1
- Sarah Cannon Research Institute at Mary Crowley, Dallas
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
În curs de recrutareFaza 1/2
- Mary Crowley Cancer Research, Dallas
Evaluation of Resection Techniques for Pancreatic Tumors
În curs de recrutareStudiu observațional
- Methodist Dallas Medical Center, Dallas
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
În curs de recrutareFaza 1/2
- NEXT Oncology - Dallas, Dallas
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
În curs de recrutareFaza 2
- Ohio State University-Telemedicine, Dallas
Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
În curs de recrutareFaza 1/2
- NEXT Oncology Dallas, Dallas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
În curs de recrutareStudiu observațional
- Massive Bio SYNERGY-AI site, Dallas
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
În curs de recrutareFaza 1/2
- Mary Crowley Cancer Research, Dallas
- University of Texas Southwestern Medical Center, Dallas
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
În curs de recrutareStudiu observațional
- Methodist Digestive Institute, Dallas
Studii pentru Cancer pancreatic în alte orașe
- Houston, TX61 studii
- New York City, NY60 studii
- Boston, MA43 studii
- Nashville, TN39 studii
- Los Angeles, CA35 studii
- St. Louis, MO33 studii
- Arlington, VA33 studii
- Baltimore, MD31 studii
- San Antonio, TX31 studii
- Philadelphia, PA26 studii
- Tampa, FL26 studii
- Durham, NC24 studii
Alte studii în Dallas
- Cancer de sân55 studii
- Cancer pulmonar cu celule non-pătrate52 studii
- Cancer metastatic42 studii
- Insuficiență cardiacă42 studii
- Cancer (toate tipurile)37 studii
- Cancer de prostată36 studii
- Cancer colorectal33 studii
- Obezitate30 studii
- Cancer ovarian28 studii
- Cancer pulmonar27 studii
- Cancer de vezică urinară27 studii
- Cancer endometrial24 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.